ABIO (ARCA Biopharma, Inc.) Bathi saben saham sajroning taun lumaku

ARCA Bio (ABIO) - logo korporat

ARCA Biopharma's experienced management is focused on scientific achievements, as evidenced by the trajectory of the current EPS YoY TTM growth rate on the GURU.Markets chart, where the value remains at 46.90. The strategy relies on the success of Gencaro trials and a personalized approach, while the work of R&D laboratories and batch production rates strictly align with the company's internal plans.

ARCA Biopharma Inc (ABIO) - Bathi resik saben saham (EPS TTM) saka 11.02.2024 nganti 20.02.2024

ABIO (ARCA Biopharma): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- indikator valuasi pasar bisnis:
Pambiji fundamental perusahaan:ARCA Biopharma Inc ABIO
Barang utama ARCA Bio

This indicator measures the rate of change in net income per share over twelve months, reflecting capital sensitivity to external shocks and liquidity. It allows for an assessment of the issuer's fundamental stability under tight monetary policy. For ARCA Biopharma (ABIO), which has no revenue, the 46.90 value confirms a stage of systematic reserve depletion. By analyzing the annual change in net income per share over a rolling period, an investor can see the actual burn rate of the cash position.